Pharmaceutical composition for anti-tumour immunotherapy

The invention relates to new use of fucoidan (Fucoidan) in synergistic enhancement of anti-tumour immunotherapy. The fucoidan is combined with an anti-tumour immunotherapeutic antibody; growth of multiple malignant tumours can be obviously inhibited; furthermore, the anti-tumour immunotherapeutic effect of an anti-tumour immunotherapeutic agent is obviously improved; and it proves that the fucoidan can be used as a functional component to prepare medicines or medical foods combined with the anti-tumour immunotherapy. 本发明涉及一种岩藻聚糖硫酸酯(Fucoidan)在协同增强抗肿瘤免疫治疗中的新用途。岩藻聚糖硫酸酯与抗肿瘤免疫治疗剂抗体联用，能显著抑制多种恶性肿瘤的生长，并明显增强抗肿瘤免疫治疗剂的抗肿瘤免疫治疗作用，证明岩藻聚糖硫酸酯可作为功能组分制备与抗肿瘤免疫疗法联用的药物或医用食品。